HCPCS Code Detail Logo

HCPCS Codes Similar to G0306

HCPCS Codes Similar to “G0306” Code.
Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count

G0307
Complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count)
Code added date: 20040101
Code effective date: 20090101
ED
Hematocrit level has exceeded 39% (or hemoglobin level has exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycle
Code added date: 20080101
Code effective date: 20080101
EE
Hematocrit level has not exceeded 39% (or hemoglobin level has not exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycle
Code added date: 20080101
Code effective date: 20080101
G9638
Final reports without documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)
Code added date: 20160101
Code effective date: 20160101
C8921
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; complete
Code added date: 20080101
Code effective date: 20080101
C8923
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, without spectral or color doppler echocardiography
Code added date: 20080101
Code effective date: 20090101
C8929
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography
Code added date: 20090101
Code effective date: 20090101
A9569
Technetium tc-99m exametazime labeled autologous white blood cells, diagnostic, per study dose
Code added date: 20080101
Code effective date: 20250101
A9570
Indium in-111 labeled autologous white blood cells, diagnostic, per study dose
Code added date: 20080101
Code effective date: 20250101
G0681
Application of a premarket approval (pma), 510(k), 361 human cells, tissues or cellular and tissue-based products (hct/p) non-sheet form skin substitute for a wound surface area up to 100 sq cm; first 25 sq cm or less of wound surface area
Code added date: 20260401
Code effective date: 20260401
G0682
Application of a premarket approval (pma), 510(k), 361 human cells, tissues or cellular and tissue-based products (hct/p) non-sheet form skin substitute for a wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)
Code added date: 20260401
Code effective date: 20260401
G0683
Application of a premarket approval (pma), 510(k), 361 human cells, tissues or cellular and tissue-based products (hct/p) non-sheet form skin substitute graft for a wound surface greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children
Code added date: 20260401
Code effective date: 20260401
G0684
Application of a premarket approval (pma), 510(k), 361 human cells, tissues or cellular and tissue-based products (hct/p) non-sheet form skin substitute graft for a wound surface greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)
Code added date: 20260401
Code effective date: 20260401
Q4433
361 hct/p skin substitute product, not otherwise specified (list in addition to primary procedure)
Code added date: 20260101
Code effective date: 20260101